M. Caby, D. Lankar, C. Vincendeau-scherrer, G. Raposo, and C. Bonnerot, Exosomal-like vesicles are present in human blood plasma, International Immunology, vol.17, issue.7, pp.879-87, 2005.
DOI : 10.1093/intimm/dxh267

C. Camps, F. Buffa, S. Colella, J. Moore, C. Sotiriou et al., hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer, Clinical Cancer Research, vol.14, issue.5, pp.1340-1348, 2008.
DOI : 10.1158/1078-0432.CCR-07-1755

V. Casadio, D. Calistri, M. Tebaldi, S. Bravaccini, R. Gunelli et al., Urine Cell-Free DNA integrity as a marker for early bladder cancer diagnosis: Preliminary data, Urologic Oncology: Seminars and Original Investigations, vol.31, issue.8
DOI : 10.1016/j.urolonc.2012.07.013

Z. Chen, Y. Li, H. Zhang, P. Huang, and R. Luthra, Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression, Oncogene, vol.65, issue.30, pp.4362-4370, 2010.
DOI : 10.1038/onc.2010.193

H. Cohen and F. Mcgovern, Renal-Cell Carcinoma, New England Journal of Medicine, vol.353, issue.23, pp.2477-90, 2005.
DOI : 10.1056/NEJMra043172

D. Elashoff, H. Zhou, J. Reiss, J. Wang, H. Xiao et al., Prevalidation of Salivary Biomarkers for Oral Cancer Detection, Cancer Epidemiology Biomarkers & Prevention, vol.21, issue.4, pp.664-72, 2012.
DOI : 10.1158/1055-9965.EPI-11-1093

G. Feng, G. Li, A. Gentil-perret, J. Tostain, and C. Genin, Elevated Serum-Circulating Rna in Patients with Conventional Renal Cell Cancer, Anticancer Res, vol.28, issue.1A, pp.321-327, 2008.

F. Gang, L. Guorong, Z. An, G. Anne, G. Christian et al., Prediction of Clear Cell Renal Cell Carcinoma by Integrity of Cell-free DNA in Serum, Urology, vol.75, issue.2, pp.262-267, 2009.
DOI : 10.1016/j.urology.2009.06.048

A. Giannakakis, R. Sandaltzopoulos, J. Greshock, S. Liang, J. Huang et al., miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer, Cancer Biology & Therapy, vol.7, issue.2, pp.255-64, 2008.
DOI : 10.4161/cbt.7.2.5297

H. Halicka, E. Bedner, and Z. Darzynkiewicz, Segregation of RNA and Separate Packaging of DNA and RNA in Apoptotic Bodies during Apoptosis, Experimental Cell Research, vol.260, issue.2, pp.248-56, 2000.
DOI : 10.1006/excr.2000.5027

D. Hasselmann, G. Rappl, W. Tilgen, and U. Reinhold, Extracellular Tyrosinase Mrna within Apoptotic Bodies Is Protected from Degradation in Human Serum, Clin Chem, vol.47, issue.8, pp.1488-1497, 2001.

S. Hauser, L. Wulfken, S. Holdenrieder, R. Moritz, C. Ohlmann et al., Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma, Cancer Epidemiology, vol.36, issue.4, pp.391-395, 2012.
DOI : 10.1016/j.canep.2012.04.001

A. Ho, X. Huang, H. Cao, C. Christman-skieller, K. Bennewith et al., Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer, Translational Oncology, vol.3, issue.2, pp.109-122, 2010.
DOI : 10.1593/tlo.09256

X. Huang, L. Ding, K. Bennewith, R. Tong, S. Welford et al., Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation, Molecular Cell, vol.35, issue.6, pp.856-67, 2009.
DOI : 10.1016/j.molcel.2009.09.006

M. Kopreski, F. Benko, L. Kwak, and C. Gocke, Detection of Tumor Messenger Rna in the Serum of Patients with Malignant Melanoma, Clin Cancer Res, vol.5, issue.8, pp.1961-1966, 1999.

B. Ljungberg, J. Jacobsen, S. Haggstrom-rudolfssson, T. Rasmuson, G. Lindh et al., Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma, Urological Research, vol.31, issue.5, pp.335-375, 2003.
DOI : 10.1007/s00240-003-0346-x

B. Ljungberg, J. Jacobsen, S. Rudolfsson, G. Lindh, K. Grankvist et al., Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma, BJU International, vol.11, issue.3, pp.661-668, 2006.
DOI : 10.1111/j.1464-410X.2006.06138.x

R. Masella, A. Cantafora, L. Guidoni, A. Luciani, G. Mariutti et al., Characterization of vesicles, containing an acylated oligopeptide, released by human colon adenocarcinoma cells, FEBS Letters, vol.239, issue.1-2, pp.25-34, 1989.
DOI : 10.1016/0014-5793(89)80246-7

P. Mitchell, R. Parkin, E. Kroh, B. Fritz, S. Wyman et al., Circulating microRNAs as stable blood-based markers for cancer detection, Proceedings of the National Academy of Sciences, vol.105, issue.30, pp.10513-10521, 2008.
DOI : 10.1073/pnas.0804549105

C. Neal, M. Michael, L. Rawlings, M. Van-der-hoek, and J. Gleadle, The VHL-dependent regulation of microRNAs in renal cancer, BMC Medicine, vol.31, issue.1, p.64, 2010.
DOI : 10.1093/nar/26.1.256

T. Pisitkun, R. Shen, and M. Knepper, Identification and proteomic profiling of exosomes in human urine, Proceedings of the National Academy of Sciences, vol.101, issue.36, pp.13368-73, 2004.
DOI : 10.1073/pnas.0403453101

K. Reddi and J. Holland, Elevated serum ribonuclease in patients with pancreatic cancer., Proceedings of the National Academy of Sciences, vol.73, issue.7, pp.2308-2318, 1976.
DOI : 10.1073/pnas.73.7.2308

M. Redova, A. Poprach, J. Nekvindova, R. Iliev, L. Radova et al., Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma, Journal of Translational Medicine, vol.10, issue.1, p.55, 2012.
DOI : 10.1183/09031936.00029610

A. Rosi, L. Guidoni, A. Luciani, G. Mariutti, and V. Viti, RNA-lipid complexes released from the plasma membrane of human colon carcinoma cells, Cancer Letters, vol.39, issue.2, pp.153-60, 1988.
DOI : 10.1016/0304-3835(88)90100-0

K. Sato, N. Tsuchiya, R. Sasaki, N. Shimoda, S. Satoh et al., Increased Serum Levels of Vascular Endothelial Growth Factor in Patients with Renal Cell Carcinoma, Japanese Journal of Cancer Research, vol.88, issue.8, pp.874-883, 1999.
DOI : 10.1111/j.1349-7006.1999.tb00829.x

M. Stroun, P. Anker, M. Beljanski, J. Henri, C. Lederrey et al., Presence of Rna in the Nucleoprotein Complex Spontaneously Released by Human Lymphocytes and Frog Auricles in Culture, Cancer Res, vol.38, issue.10, pp.3546-54, 1978.

M. Tsujiura, D. Ichikawa, S. Komatsu, A. Shiozaki, H. Takeshita et al., Circulating microRNAs in plasma of patients with gastric cancers, British Journal of Cancer, vol.6, issue.7, pp.1174-1183, 2010.
DOI : 10.1038/labinvest.2008.94

V. Urquidi, C. Rosser, and S. Goodison, Molecular Diagnostic Trends in Urological Cancer: Biomarkers for Non-Invasive Diagnosis, Current Medicinal Chemistry, vol.19, issue.22, pp.3653-63, 2012.
DOI : 10.2174/092986712801661103

G. Van-niel, I. Porto-carreiro, S. Simoes, and G. Raposo, Exosomes: A Common Pathway for a Specialized Function, Journal of Biochemistry, vol.140, issue.1, pp.13-21, 2006.
DOI : 10.1093/jb/mvj128

N. White and G. Yousef, MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer, BMC Medicine, vol.389, issue.1, p.65, 2010.
DOI : 10.1515/BC.2008.068

A. Wieczorek, C. Rhyner, and L. Block, Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans., Proceedings of the National Academy of Sciences, vol.82, issue.10, pp.3455-3464, 1985.
DOI : 10.1073/pnas.82.10.3455

L. Wulfken, R. Moritz, C. Ohlmann, S. Holdenrieder, V. Jung et al., MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels, PLoS ONE, vol.50, issue.9, p.25787, 2011.
DOI : 10.1371/journal.pone.0025787.s002

Y. Youssef, N. White, J. Grigull, A. Krizova, C. Samy et al., Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature, European Urology, vol.59, issue.5, pp.721-751, 2011.
DOI : 10.1016/j.eururo.2011.01.004

A. Zhao, G. Li, M. Peoc-'h, C. Genin, and M. Gigante, Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma, Experimental and Molecular Pathology, vol.94, issue.1, pp.115-135, 2012.
DOI : 10.1016/j.yexmp.2012.10.005

J. Arroyo, J. Chevillet, E. Kroh, I. Ruf, C. Pritchard et al., Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, Proceedings of the National Academy of Sciences, vol.108, issue.12, pp.5003-5011, 2011.
DOI : 10.1073/pnas.1019055108

J. Ragoussis, hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer, Clin Cancer Res, vol.14, issue.5, pp.1340-1348, 2008.

F. Montorsi and P. Karakiewicz, A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study, BJU Int, vol.103, issue.11, pp.1496-500, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00354593

E. Cocucci, G. Racchetti, and J. Meldolesi, Shedding microvesicles: artefacts no more, Trends in Cell Biology, vol.19, issue.2, pp.43-51, 2009.
DOI : 10.1016/j.tcb.2008.11.003

H. Cohen and F. Mcgovern, Renal-Cell Carcinoma, New England Journal of Medicine, vol.353, issue.23, pp.2477-90, 2005.
DOI : 10.1056/NEJMra043172

B. Curti, Renal Cell Carcinoma, JAMA, vol.292, issue.1, pp.97-100, 2004.
DOI : 10.1001/jama.292.1.97

D. Messadi, M. Wang, V. Nabili, M. Lingen, D. Morris et al., Prevalidation of salivary biomarkers for oral cancer detection, Cancer Epidemiol Biomarkers Prev, vol.21, issue.4, pp.664-72, 2012.

R. Figlin, W. Pierce, R. Kaboo, C. Tso, N. Moldawer et al., Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumor, J Urol, vol.1583, issue.1, pp.740-745, 1997.

S. Fuhrman, L. Lasky, and C. Limas, Prognostic significance of morphologic parameters in renal cell carcinoma, The American Journal of Surgical Pathology, vol.6, issue.7, pp.655-63, 1982.
DOI : 10.1097/00000478-198210000-00007

R. Garzon, G. Calin, and C. Croce, MicroRNAs in Cancer, Annual Review of Medicine, vol.60, issue.1, pp.167-79, 2009.
DOI : 10.1146/annurev.med.59.053006.104707

D. Hasselmann, G. Rappl, W. Tilgen, and U. Reinhold, Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum, Clin Chem, vol.47, issue.8, pp.1488-1497, 2001.

S. Hauser, L. Wulfken, S. Holdenrieder, R. Moritz, C. Ohlmann et al., Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma, Cancer Epidemiology, vol.36, issue.4, pp.391-395, 2012.
DOI : 10.1016/j.canep.2012.04.001

A. Ho, X. Huang, H. Cao, C. Christman-skieller, K. Bennewith et al., Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer, Translational Oncology, vol.3, issue.2, pp.109-122, 2010.
DOI : 10.1593/tlo.09256

Y. Huang, Y. Dai, Y. J. Chen, T. Yin, Y. Tang et al., Microarray analysis of microRNA expression in renal clear cell carcinoma, European Journal of Surgical Oncology (EJSO), vol.35, issue.10, pp.1119-1142, 2009.
DOI : 10.1016/j.ejso.2009.04.010

M. Inui, G. Martello, and S. Piccolo, MicroRNA control of signal transduction, Nature Reviews Molecular Cell Biology, vol.9, issue.3, pp.252-63, 2010.
DOI : 10.1038/nrm2868

T. Jamaspishvili, M. Kral, I. Khomeriki, V. Student, Z. Kolar et al., Urine markers in monitoring for prostate cancer, Prostate Cancer and Prostatic Diseases, vol.35, issue.1, pp.12-21, 2009.
DOI : 10.1371/journal.pone.0004995

N. Kosaka, H. Iguchi, Y. Yoshioka, F. Takeshita, Y. Matsuki et al., Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells, Journal of Biological Chemistry, vol.285, issue.23, pp.17442-52, 2010.
DOI : 10.1074/jbc.M110.107821

K. Livak and T. Schmittgen, Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2???????CT Method, Methods, vol.25, issue.4, pp.402-410, 2001.
DOI : 10.1006/meth.2001.1262

J. Noteboom, O. Briant, K. Allen, A. Lin, D. Urban et al., Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci, vol.105, issue.30, pp.10513-10521, 2008.

O. Slaby, Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma, J Transl Med, vol.10, p.55, 2012.

R. Siegel, D. Naishadham, and A. Jemal, Cancer statistics, 2013, CA: A Cancer Journal for Clinicians, vol.287, issue.suppl 5, pp.11-30, 2013.
DOI : 10.3322/caac.21166

A. Skolarikos, G. Alivizatos, P. Laguna, and J. De-la-rosette, A Review on Follow-Up Strategies for Renal Cell Carcinoma after Nephrectomy, European Urology, vol.51, issue.6, pp.1490-500, 2007.
DOI : 10.1016/j.eururo.2006.12.031

L. Sobin and C. Wittekind, TNM classification of malignant tumors, 0193.

V. Urquidi, C. Rosser, and S. Goodison, Molecular Diagnostic Trends in Urological Cancer: Biomarkers for Non-Invasive Diagnosis, Current Medicinal Chemistry, vol.19, issue.22, pp.3653-63, 2012.
DOI : 10.2174/092986712801661103

H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J. Lee et al., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nature Cell Biology, vol.175, issue.6, 2007.
DOI : 10.1002/pmic.200400876

K. Vickers, B. Palmisano, B. Shoucri, R. Shamburek, and A. Remaley, MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, Nature Cell Biology, vol.257, issue.4, pp.423-456, 2011.
DOI : 10.1073/pnas.011404098

G. Wang, E. Chan, B. Kwan, P. Li, S. Yip et al., Expression of microRNAs in the Urine of Patients With Bladder Cancer, Clinical Genitourinary Cancer, vol.10, issue.2, pp.106-119, 2012.
DOI : 10.1016/j.clgc.2012.01.001

L. Wulfken, R. Moritz, C. Ohlmann, S. Holdenrieder, V. Jung et al., MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels, PLoS ONE, vol.50, issue.9, p.25787, 2011.
DOI : 10.1371/journal.pone.0025787.s002

Y. Youssef, N. White, J. Grigull, A. Krizova, C. Samy et al., Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature, European Urology, vol.59, issue.5, 2011.
DOI : 10.1016/j.eururo.2011.01.004

A. Zhao, G. Li, M. Peoc-'h, C. Genin, and M. Gigante, Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma, Experimental and Molecular Pathology, vol.94, issue.1, pp.115-135, 2012.
DOI : 10.1016/j.yexmp.2012.10.005

J. Arroyo, J. Chevillet, E. Kroh, I. Ruf, C. Pritchard et al., Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma, Proceedings of the National Academy of Sciences, vol.108, issue.12, pp.5003-5011, 2011.
DOI : 10.1073/pnas.1019055108

M. Badger and G. Price, Carbonic Anhydrase Activity Associated with the Cyanobacterium Synechococcus PCC7942, PLANT PHYSIOLOGY, vol.89, issue.1, pp.51-60, 1989.
DOI : 10.1104/pp.89.1.51

R. Barber, D. Harmer, R. Coleman, and B. Clark, GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues, Physiological Genomics, vol.21, issue.3, pp.389-95, 2005.
DOI : 10.1152/physiolgenomics.00025.2005

D. Bates, T. Cui, J. Doughty, M. Winkler, M. Sugiono et al., Vegf165b, an Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Is Down-Regulated in Renal Cell Carcinoma, Cancer Res, vol.62, issue.14, pp.4123-4154, 2002.

E. Berezikov, V. Guryev, J. Van-de-belt, E. Wienholds, R. Plasterk et al., Phylogenetic Shadowing and Computational Identification of Human microRNA Genes, Cell, vol.120, issue.1, pp.21-25, 2005.
DOI : 10.1016/j.cell.2004.12.031

C. Beyer and D. Pisetsky, The role of microparticles in the pathogenesis of rheumatic diseases, Nature Reviews Rheumatology, vol.19, issue.1, pp.21-30, 2009.
DOI : 10.1038/nrrheum.2009.229

M. Blinov, I. Luganova, and A. Vladimirova, Factors of a Nucleic Nature in Human Blood Plasma], Vopr Med Khim, vol.27, issue.5, pp.600-603, 1981.

P. Blower, J. Chung, J. Verducci, S. Lin, J. Park et al., MicroRNAs modulate the chemosensitivity of tumor cells, Micrornas Modulate the Chemosensitivity of Tumor Cells, pp.1-9, 2008.
DOI : 10.1158/1535-7163.MCT-07-0573

G. Bocci, S. Man, S. Green, G. Francia, J. Ebos et al., Increased Plasma Vascular Endothelial Growth Factor (VEGF) as a Surrogate Marker for Optimal Therapeutic Dosing of VEGF Receptor-2 Monoclonal Antibodies, Cancer Research, vol.64, issue.18, pp.6616-6641, 2004.
DOI : 10.1158/0008-5472.CAN-04-0401

W. Brenner, G. Farber, T. Herget, H. Lehr, J. Hengstler et al., Loss of tumor suppressor protein PTEN during renal carcinogenesis, International Journal of Cancer, vol.57, issue.1, pp.53-60, 2002.
DOI : 10.1002/ijc.10303

O. Bryzgunova, T. Skvortsova, E. Kolesnikova, A. Starikov, E. Rykova et al., Isolation and Comparative Study of Cell-Free Nucleic Acids from Human Urine, Annals of the New York Academy of Sciences, vol.48, issue.1, pp.334-374, 2006.
DOI : 10.1158/1078-0432.CCR-04-0597

M. Caby, D. Lankar, C. Vincendeau-scherrer, G. Raposo, and C. Bonnerot, Exosomal-like vesicles are present in human blood plasma, International Immunology, vol.17, issue.7, pp.879-87, 2005.
DOI : 10.1093/intimm/dxh267

G. Calin and C. Croce, MicroRNA signatures in human cancers, Nature Reviews Cancer, vol.59, issue.11, pp.857-66, 2006.
DOI : 10.1677/erc.1.01209

G. Calin, C. Dumitru, M. Shimizu, R. Bichi, S. Zupo et al., Frequent Deletions and Down-Regulation of Micro-Rna Genes Mir15 and Mir16 at 13q14 in Chronic Lymphocytic Leukemia, Proc Natl Acad Sci, issue.24, pp.99-15524, 2002.

C. Camps, F. Buffa, S. Colella, J. Moore, C. Sotiriou et al., hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer, Clinical Cancer Research, vol.14, issue.5, pp.1340-1348, 2008.
DOI : 10.1158/1078-0432.CCR-07-1755

G. Camussi, M. Deregibus, S. Bruno, V. Cantaluppi, and L. Biancone, Exosomes/microvesicles as a mechanism of cell-to-cell communication, Kidney International, vol.78, issue.9, pp.838-886, 2010.
DOI : 10.1038/ki.2010.278

F. Montorsi and P. Karakiewicz, A Critical Assessment of the Prognostic Value of Clear Cell, Papillary and Chromophobe Histological Subtypes in Renal Cell Carcinoma: A Population-Based Study, BJU Int, vol.103, issue.11, pp.1496-500, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00354593

V. Casadio, D. Calistri, M. Tebaldi, S. Bravaccini, R. Gunelli et al., Urine Cell-Free DNA integrity as a marker for early bladder cancer diagnosis: Preliminary data, Urologic Oncology: Seminars and Original Investigations, vol.31, issue.8
DOI : 10.1016/j.urolonc.2012.07.013

V. Casadio, D. Calistri, M. Tebaldi, S. Bravaccini, R. Gunelli et al., Urine Cell-Free DNA integrity as a marker for early bladder cancer diagnosis: Preliminary data, Urologic Oncology: Seminars and Original Investigations, vol.31, issue.8, 2012.
DOI : 10.1016/j.urolonc.2012.07.013

Z. Chen, Y. Li, H. Zhang, P. Huang, and R. Luthra, Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression, Oncogene, vol.65, issue.30, pp.4362-4370, 2010.
DOI : 10.1038/onc.2010.193

W. Cho, OncomiRs: the discovery and progress of microRNAs in cancers, Molecular Cancer, vol.6, issue.1, p.60, 2007.
DOI : 10.1186/1476-4598-6-60

W. Chow, J. Mclaughlin, J. Mandel, S. Wacholder, S. Niwa et al., Obesity and Risk of Renal Cell Cancer, Cancer Epidemiol Biomarkers Prev, vol.5, issue.1, pp.17-21, 1996.

P. Clark, Recent advances in targeted therapy for renal cell carcinoma, Current Opinion in Urology, vol.17, issue.5, pp.331-337, 2007.
DOI : 10.1097/MOU.0b013e3282c508e0

E. Cocucci, G. Racchetti, and J. Meldolesi, Shedding microvesicles: artefacts no more, Trends in Cell Biology, vol.19, issue.2, pp.43-51, 2009.
DOI : 10.1016/j.tcb.2008.11.003

H. Cohen and F. Mcgovern, Renal-Cell Carcinoma, New England Journal of Medicine, vol.353, issue.23, pp.2477-90, 2005.
DOI : 10.1056/NEJMra043172

B. Curti, Renal Cell Carcinoma, JAMA, vol.292, issue.1, pp.97-100, 2004.
DOI : 10.1001/jama.292.1.97

K. Datta, S. Mondal, S. Sinha, J. Li, E. Wang et al., Role of elongin-binding domain of von hippel lindau gene product on HuR-mediated VPF/VEGF mRNA stability in renal cell carcinoma, Oncogene, vol.46, issue.53, pp.7850-7858, 2005.
DOI : 10.1042/BST0300952

W. De-riese, W. Crabtree, E. Allhoff, M. Werner, S. Liedke et al., Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma., Journal of Clinical Oncology, vol.11, issue.9, pp.1804-1812, 1993.
DOI : 10.1200/JCO.1993.11.9.1804

R. Dhote, M. Pellicer-coeuret, N. Thiounn, B. Debre, and G. Vidal-trecan, Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention, BJU International, vol.9, issue.1, pp.20-27, 2000.
DOI : 10.1046/j.1464-410x.2000.00708.x

M. Dimopoulos, L. Moulopoulos, C. Costantinides, C. Deliveliotis, D. Pantazopoulos et al., Prunart Renal Lymphoma: A Clinical and Radiological Study, The Journal of Urology, vol.155, issue.6, pp.1865-1872, 1996.
DOI : 10.1016/S0022-5347(01)66031-2

K. Dutta, Y. Zhong, Y. Liu, T. Yamada, S. Akatsuka et al., Association of microRNA-34a overexpression with proliferation is cell type-dependent, Cancer Science, vol.123, issue.12, pp.1845-52, 2007.
DOI : 10.1073/pnas.0307323101

J. Ebos, G. Bocci, S. Man, P. Thorpe, D. Hicklin et al., A Naturally Occurring Soluble Form of Vascular Endothelial Growth Factor Receptor 2 Detected in Mouse and Human Plasma, Mol Cancer Res, vol.2, issue.6, pp.315-341, 2004.

S. Edge and C. Compton, The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM, Annals of Surgical Oncology, vol.17, issue.6, pp.1471-1475, 2010.
DOI : 10.1245/s10434-010-0985-4

D. Elashoff, H. Zhou, J. Reiss, J. Wang, H. Xiao et al., Prevalidation of Salivary Biomarkers for Oral Cancer Detection, Cancer Epidemiology Biomarkers & Prevention, vol.21, issue.4, pp.664-72, 2012.
DOI : 10.1158/1055-9965.EPI-11-1093

B. Escudier and L. Albiges, Vascular Endothelial Growth Factor-Targeted Therapy for the Treatment of Renal Cell Carcinoma, Drugs, vol.65, issue.10, pp.1179-91, 2011.
DOI : 10.2165/11591410-000000000-00000

V. Fadok, D. Bratton, D. Rose, A. Pearson, R. Ezekewitz et al., A receptor for phosphatidylserine-specific clearance of apoptotic cells, Nature, vol.405, issue.6782, pp.85-90, 2000.
DOI : 10.1038/35011084

G. Feng, G. Li, A. Gentil-perret, J. Tostain, and C. Genin, Elevated Serum-Circulating Rna in Patients with Conventional Renal Cell Cancer, Anticancer Res, vol.28, issue.1A, pp.321-327, 2008.

R. Figlin, W. Pierce, R. Kaboo, C. Tso, N. Moldawer et al., Treatment of Metastatic Renal Cell Carcinoma with Nephrectomy, Interleukin-2 and Cytokine-Primed or Cd8(+) Selected Tumor Infiltrating Lymphocytes from Primary Tumor, J Urol, vol.1583, issue.1, pp.740-745, 1997.

J. Fish, M. Santoro, S. Morton, S. Yu, R. Yeh et al., miR-126 Regulates Angiogenic Signaling and Vascular Integrity, Developmental Cell, vol.15, issue.2, pp.272-84, 2008.
DOI : 10.1016/j.devcel.2008.07.008

URL : http://doi.org/10.1016/j.devcel.2008.07.008

L. Fontana, M. Fiori, S. Albini, L. Cifaldi, S. Giovinazzi et al., Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM, PLoS ONE, vol.5, issue.5, p.2236, 2008.
DOI : 10.1371/journal.pone.0002236.s001

S. Fuhrman, L. Lasky, and C. Limas, Prognostic significance of morphologic parameters in renal cell carcinoma, The American Journal of Surgical Pathology, vol.6, issue.7, pp.655-63, 1982.
DOI : 10.1097/00000478-198210000-00007

J. Fujita, M. Kraus, H. Onoue, S. Srivastava, Y. Ebi et al., Activated H-Ras Oncogenes in Human Kidney Tumors, Cancer Res, vol.48, issue.18, pp.5251-5256, 1988.

B. Furusato, A. Mohamed, M. Uhlen, and J. Rhim, CXCR4 and cancer, Pathology International, vol.108, issue.1, pp.497-505, 2010.
DOI : 10.1111/j.1440-1827.2010.02548.x

F. Gang, L. Guorong, Z. An, G. Anne, G. Christian et al., Prediction of Clear Cell Renal Cell Carcinoma by Integrity of Cell-free DNA in Serum, Urology, vol.75, issue.2, pp.262-267, 2009.
DOI : 10.1016/j.urology.2009.06.048

R. Garzon, G. Calin, and C. Croce, MicroRNAs in Cancer, Annual Review of Medicine, vol.60, issue.1, pp.167-79, 2009.
DOI : 10.1146/annurev.med.59.053006.104707

A. Giannakakis, R. Sandaltzopoulos, J. Greshock, S. Liang, J. Huang et al., miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer, Cancer Biology & Therapy, vol.7, issue.2, pp.255-64, 2008.
DOI : 10.4161/cbt.7.2.5297

H. Halicka, E. Bedner, and Z. Darzynkiewicz, Segregation of RNA and Separate Packaging of DNA and RNA in Apoptotic Bodies during Apoptosis, Experimental Cell Research, vol.260, issue.2, pp.248-56, 2000.
DOI : 10.1006/excr.2000.5027

S. Hara, M. Oya, R. Mizuno, A. Horiguchi, K. Marumo et al., Akt activation in renal cell carcinoma: contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor, Annals of Oncology, vol.16, issue.6, pp.928-961, 2005.
DOI : 10.1093/annonc/mdi182

D. Hasselmann, G. Rappl, W. Tilgen, and U. Reinhold, Extracellular Tyrosinase Mrna within Apoptotic Bodies Is Protected from Degradation in Human Serum, Clin Chem, vol.47, issue.8, pp.1488-1497, 2001.

S. Hauser, L. Wulfken, S. Holdenrieder, R. Moritz, C. Ohlmann et al., Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma, Cancer Epidemiology, vol.36, issue.4, pp.391-395, 2012.
DOI : 10.1016/j.canep.2012.04.001

B. Hemmerlein, A. Kugler, R. Ozisik, R. Ringert, H. Radzun et al., Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas, Virchows Archiv, vol.439, issue.5, pp.645-52, 2001.
DOI : 10.1007/s004280100464

A. Ho, X. Huang, H. Cao, C. Christman-skieller, K. Bennewith et al., Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer, Translational Oncology, vol.3, issue.2, pp.109-122, 2010.
DOI : 10.1593/tlo.09256

M. Hristov, E. W. Linder, S. Weber, and P. , Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro, Blood, vol.104, issue.9, pp.2761-2767, 2004.
DOI : 10.1182/blood-2003-10-3614

X. Huang, L. Ding, K. Bennewith, R. Tong, S. Welford et al., Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation, Molecular Cell, vol.35, issue.6, pp.856-67, 2009.
DOI : 10.1016/j.molcel.2009.09.006

Y. Huang, Y. Dai, Y. J. Chen, T. Yin, Y. Tang et al., Microarray analysis of microRNA expression in renal clear cell carcinoma, European Journal of Surgical Oncology (EJSO), vol.35, issue.10, pp.1119-1142, 2009.
DOI : 10.1016/j.ejso.2009.04.010

Z. Huang, D. Huang, S. Ni, Z. Peng, W. Sheng et al., Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer, International Journal of Cancer, vol.10, issue.1, pp.118-144, 2009.
DOI : 10.1002/ijc.25007

B. Hugel, M. Martinez, C. Kunzelmann, and J. Freyssinet, Membrane Microparticles: Two Sides of the Coin, Physiology, vol.20, issue.1, pp.22-29, 2005.
DOI : 10.1152/physiol.00029.2004

M. Hunter, N. Ismail, X. Zhang, B. Aguda, E. Lee et al., Detection of microRNA Expression in Human Peripheral Blood Microvesicles, PLoS ONE, vol.15, issue.11, p.3694, 2008.
DOI : 10.1371/journal.pone.0003694.s003

M. Inui, G. Martello, and S. Piccolo, MicroRNA control of signal transduction, Nature Reviews Molecular Cell Biology, vol.9, issue.3, pp.252-63, 2010.
DOI : 10.1038/nrm2868

S. Ivanov, S. Liao, A. Ivanova, A. Danilkovitch-miagkova, N. Tarasova et al., Expression of Hypoxia-Inducible Cell-Surface Transmembrane Carbonic Anhydrases in Human Cancer, The American Journal of Pathology, vol.158, issue.3, pp.905-924, 2001.
DOI : 10.1016/S0002-9440(10)64038-2

J. Jacobsen, T. Rasmuson, K. Grankvist, and B. Ljungberg, VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA, The Journal of Urology, vol.163, issue.1, pp.343-350, 2000.
DOI : 10.1016/S0022-5347(05)68049-4

S. Jahr, H. Hentze, S. Englisch, D. Hardt, F. Fackelmayer et al., DNA Fragments in the Blood Plasma of Cancer Patients: Quantitations and Evidence for Their Origin from Apoptotic and Necrotic Cells, Cancer Res, vol.61, issue.4, pp.1659-65, 2001.

T. Jamaspishvili, M. Kral, I. Khomeriki, V. Student, Z. Kolar et al., Urine markers in monitoring for prostate cancer, Prostate Cancer and Prostatic Diseases, vol.35, issue.1, pp.12-21, 2009.
DOI : 10.1371/journal.pone.0004995

R. Johnstone, Exosomes biological significance: A concise review, Blood Cells, Molecules, and Diseases, vol.36, issue.2, pp.315-336, 2006.
DOI : 10.1016/j.bcmd.2005.12.001

R. Kamm and A. Smith, Nucleic Acid Concentrations in Normal Human Plasma, Clin Chem, vol.18, issue.6, pp.519-541, 1972.

P. Keck, S. Hauser, G. Krivi, K. Sanzo, T. Warren et al., Vascular permeability factor, an endothelial cell mitogen related to PDGF, Science, vol.246, issue.4935, pp.1309-1321, 1989.
DOI : 10.1126/science.2479987

M. Kopreski, F. Benko, L. Kwak, and C. Gocke, Detection of Tumor Messenger Rna in the Serum of Patients with Malignant Melanoma, Clin Cancer Res, vol.5, issue.8, pp.1961-1966, 1999.

M. Korpal, E. Lee, G. Hu, and Y. Kang, The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2, Journal of Biological Chemistry, vol.283, issue.22, pp.14910-14914, 2008.
DOI : 10.1074/jbc.C800074200

N. Kosaka, H. Iguchi, Y. Yoshioka, F. Takeshita, Y. Matsuki et al., Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells, Journal of Biological Chemistry, vol.285, issue.23, pp.17442-52, 2010.
DOI : 10.1074/jbc.M110.107821

J. Krutzfeldt, N. Rajewsky, R. Braich, K. Rajeev, T. Tuschl et al., Silencing of microRNAs in vivo with ???antagomirs???, Nature, vol.33, issue.7068, pp.685-694, 2005.
DOI : 10.1038/nature04303

H. Kume, S. Takahashi, S. Teramoto, and K. Isurugi, Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention, BJU International, vol.88, issue.7, p.804, 2001.
DOI : 10.1093/jnci/91.10.854

M. Lagos-quintana, R. Rauhut, W. Lendeckel, and T. Tuschl, Identification of Novel Genes Coding for Small Expressed RNAs, Science, vol.294, issue.5543, pp.853-861, 2001.
DOI : 10.1126/science.1064921

T. Lange, N. Guttmann-raviv, L. Baruch, M. Machluf, and G. Neufeld, VEGF162, A New Heparin-binding Vascular Endothelial Growth Factor Splice Form That Is Expressed in Transformed Human Cells, Journal of Biological Chemistry, vol.278, issue.19, pp.17164-17173, 2003.
DOI : 10.1074/jbc.M212224200

N. Lau, L. Lim, E. Weinstein, and D. Bartel, An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans, Science, vol.294, issue.5543, pp.858-62, 2001.
DOI : 10.1126/science.1065062

R. Lee and A. V. , An Extensive Class of Small RNAs in Caenorhabditis elegans, Science, vol.294, issue.5543, pp.862-866, 2001.
DOI : 10.1126/science.1065329

D. Leung, G. Cachianes, W. Kuang, D. Goeddel, and N. Ferrara, Vascular endothelial growth factor is a secreted angiogenic mitogen, Science, vol.246, issue.4935, pp.1306-1315, 1989.
DOI : 10.1126/science.2479986

F. Levi, J. Ferlay, C. Galeone, F. Lucchini, E. Negri et al., The changing pattern of kidney cancer incidence and mortality in Europe, BJU International, vol.353, issue.8, pp.949-58, 2008.
DOI : 10.1111/j.1464-410X.2008.07451.x

A. Levy, N. Levy, and M. Goldberg, Post-transcriptional Regulation of Vascular Endothelial Growth Factor by Hypoxia, Journal of Biological Chemistry, vol.271, issue.5, pp.2746-53, 1996.
DOI : 10.1074/jbc.271.5.2746

A. Li, N. Omura, S. Hong, A. Vincent, K. Walter et al., Pancreatic Cancers Epigenetically Silence SIP1 and Hypomethylate and Overexpress miR-200a/200b in Association with Elevated Circulating miR-200a and miR-200b Levels, Cancer Research, vol.70, issue.13, pp.5226-5263, 2010.
DOI : 10.1158/0008-5472.CAN-09-4227

G. Li, M. Cuilleron, M. Cottier, A. Gentil-perret, C. Lambert et al., The Use of MN/CA9 Gene Expression in Identifying Malignant Solid Renal Tumors, European Urology, vol.49, issue.2, pp.401-406, 2006.
DOI : 10.1016/j.eururo.2005.10.025

G. Li, M. Cuilleron, A. Gentil-perret, M. Cottier, K. Passebosc-faure et al., Rapid and Sensitive Detection of Messenger Rna Expression for Molecular Differential Diagnosis of Renal Cell Carcinoma, Clin Cancer Res, vol.9, issue.17, pp.6441-6447, 2003.

G. Li, G. Feng, A. Gentil-perret, C. Genin, and J. Tostain, CA9 gene expression in conventional renal cell carcinoma: a potential marker for prediction of early metastasis after nephrectomy, Clinical & Experimental Metastasis, vol.64, issue.3, pp.149-55, 2007.
DOI : 10.1007/s10585-007-9064-z

G. Li, K. Passebosc-faure, C. Lambert, A. Gentil-perret, F. Blanc et al., The Expression of G250/Mn/Ca9 Antigen by Flow Cytometry: Its Possible Implication for Detection of Micrometastatic Renal Cancer Cells, Clin Cancer Res, vol.7, issue.1, pp.89-92, 2001.

H. Liu, A. Brannon, A. Reddy, G. Alexe, M. Seiler et al., Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma, BMC Systems Biology, vol.4, issue.1, p.51, 2010.
DOI : 10.1186/1752-0509-4-51

K. Livak and T. Schmittgen, Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2???????CT Method, Methods, vol.25, issue.4, pp.402-410, 2001.
DOI : 10.1006/meth.2001.1262

B. Ljungberg, J. Jacobsen, S. Haggstrom-rudolfssson, T. Rasmuson, G. Lindh et al., Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma, Urological Research, vol.31, issue.5, pp.335-375, 2003.
DOI : 10.1007/s00240-003-0346-x

B. Ljungberg, J. Jacobsen, S. Rudolfsson, G. Lindh, K. Grankvist et al., Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma, BJU International, vol.11, issue.3, pp.661-668, 2006.
DOI : 10.1111/j.1464-410X.2006.06138.x

Y. Lo, Circulating Nucleic Acids in Plasma and Serum: An Overview, Annals of the New York Academy of Sciences, vol.46, issue.1, pp.1-7, 2001.
DOI : 10.1111/j.1749-6632.2001.tb03858.x

J. Lu, G. Getz, E. Miska, E. Alvarez-saavedra, J. Lamb et al., MicroRNA expression profiles classify human cancers, Nature, vol.1, issue.7043, pp.834-842, 2005.
DOI : 10.1016/S1535-6108(02)00018-1

R. Masella, A. Cantafora, L. Guidoni, A. Luciani, G. Mariutti et al., Characterization of vesicles, containing an acylated oligopeptide, released by human colon adenocarcinoma cells, FEBS Letters, vol.239, issue.1-2, pp.25-34, 1989.
DOI : 10.1016/0014-5793(89)80246-7

A. Mathew, S. Devesa, J. Fraumeni, J. Chow, and W. , Global increases in kidney cancer incidence, 1973???1992, European Journal of Cancer Prevention, vol.11, issue.2, pp.171-179, 2002.
DOI : 10.1097/00008469-200204000-00010

N. Meldrum and F. Roughton, The state of carbon dioxide in blood, The Journal of Physiology, vol.80, issue.2, pp.143-70, 1933.
DOI : 10.1113/jphysiol.1933.sp003078

P. Mitchell, R. Parkin, E. Kroh, B. Fritz, S. Wyman et al., Circulating microRNAs as stable blood-based markers for cancer detection, Proceedings of the National Academy of Sciences, vol.105, issue.30, pp.10513-10521, 2008.
DOI : 10.1073/pnas.0804549105

O. Morel, F. Toti, B. Hugel, B. Bakouboula, L. Camoin-jau et al., Procoagulant Microparticles: Disrupting the Vascular Homeostasis Equation?, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.26, issue.12, pp.2594-604, 2006.
DOI : 10.1161/01.ATV.0000246775.14471.26

R. Motzer and N. Bander, Renal-Cell Carcinoma, New England Journal of Medicine, vol.335, issue.12, pp.865-75, 1996.
DOI : 10.1056/NEJM199609193351207

D. Mukhopadhyay and K. Datta, Multiple regulatory pathways of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in tumors, Seminars in Cancer Biology, vol.14, issue.2, pp.123-153, 2004.
DOI : 10.1016/j.semcancer.2003.09.019

D. Mukhopadhyay, B. Knebelmann, H. Cohen, S. Ananth, and V. Sukhatme, The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity., Molecular and Cellular Biology, vol.17, issue.9, pp.5629-5668, 1997.
DOI : 10.1128/MCB.17.9.5629

C. Neal, M. Michael, L. Rawlings, M. Van-der-hoek, and J. Gleadle, The VHL-dependent regulation of microRNAs in renal cancer, BMC Medicine, vol.31, issue.1, p.64, 2010.
DOI : 10.1093/nar/26.1.256

E. Ng, W. Chong, J. H. Lam, E. Shin, V. et al., Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening, Gut, vol.58, issue.10, pp.1375-81, 2009.
DOI : 10.1136/gut.2008.167817

E. Ng, N. Tsui, N. Lam, R. Chiu, S. Yu et al., Presence of Filterable and Nonfilterable Mrna in the Plasma of Cancer Patients and Healthy Individuals, Clin Chem, vol.48, issue.8, pp.1212-1219, 2002.

S. Pal, K. Datta, R. Khosravi-far, and D. Mukhopadhyay, Role of Protein Kinase C?? in Ras-mediated Transcriptional Activation of Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression, Journal of Biological Chemistry, vol.276, issue.4, pp.2395-403, 2001.
DOI : 10.1074/jbc.M007818200

A. Pantuck, D. Seligson, T. Klatte, H. Yu, J. Leppert et al., Prognostic relevance of the mTOR pathway in renal cell carcinoma, Cancer, vol.9, issue.11, pp.2257-67, 2007.
DOI : 10.1002/cncr.22677

S. Park, A. Gaur, E. Lengyel, and M. Peter, The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2, Genes & Development, vol.22, issue.7, pp.894-907, 2008.
DOI : 10.1101/gad.1640608

J. Patard, D. Pouessel, and S. Culine, New therapies in renal cell carcinoma, Current Opinion in Supportive and Palliative Care, vol.1, issue.3, pp.174-183, 2007.
DOI : 10.1097/SPC.0b013e3282f1238b

URL : https://hal.archives-ouvertes.fr/hal-00315884

L. Pigati, S. Yaddanapudi, R. Iyengar, D. Kim, S. Hearn et al., Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells, PLoS ONE, vol.8, issue.10, p.13515, 2010.
DOI : 10.1371/journal.pone.0013515.s012

R. Pillai, S. Bhattacharyya, and W. Filipowicz, Repression of protein synthesis by miRNAs: how many mechanisms?, Trends in Cell Biology, vol.17, issue.3, pp.118-144, 2007.
DOI : 10.1016/j.tcb.2006.12.007

T. Pisitkun, R. Shen, and M. Knepper, Identification and proteomic profiling of exosomes in human urine, Proceedings of the National Academy of Sciences, vol.101, issue.36, pp.13368-73, 2004.
DOI : 10.1073/pnas.0403453101

M. Puissegur, N. Mazure, T. Bertero, L. Pradelli, S. Grosso et al., miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity, Cell Death and Differentiation, vol.342, issue.3, pp.465-78
DOI : 10.1093/bioinformatics/btm106

URL : https://hal.archives-ouvertes.fr/hal-00546747

L. Quero, L. Dubois, N. Lieuwes, and C. Hennequin, miR-210 as a marker of chronic hypoxia, but not a therapeutic target in prostate cancer, Radiotherapy and Oncology, vol.101, issue.1, pp.203-211
DOI : 10.1016/j.radonc.2011.05.063

K. Reddi and J. Holland, Elevated serum ribonuclease in patients with pancreatic cancer., Proceedings of the National Academy of Sciences, vol.73, issue.7, pp.2308-2318, 1976.
DOI : 10.1073/pnas.73.7.2308

M. Redova, A. Poprach, J. Nekvindova, R. Iliev, L. Radova et al., Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma, Journal of Translational Medicine, vol.10, issue.1, p.55, 2012.
DOI : 10.1183/09031936.00029610

C. Richard and J. Blay, Cxcr4 in Cancer and Its Regulation by Ppargamma, PPAR Res, p.769413, 2008.

A. Rosi, L. Guidoni, A. Luciani, G. Mariutti, and V. Viti, RNA-lipid complexes released from the plasma membrane of human colon carcinoma cells, Cancer Letters, vol.39, issue.2, pp.153-60, 1988.
DOI : 10.1016/0304-3835(88)90100-0

G. Ruvkun, MOLECULAR BIOLOGY: Glimpses of a Tiny RNA World, Science, vol.294, issue.5543, pp.797-806, 2001.
DOI : 10.1126/science.1066315

Y. Saito, G. Liang, G. Egger, J. Friedman, J. Chuang et al., Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells, Cancer Cell, vol.9, issue.6, pp.435-478, 2006.
DOI : 10.1016/j.ccr.2006.04.020

K. Sato, N. Tsuchiya, R. Sasaki, N. Shimoda, S. Satoh et al., Increased Serum Levels of Vascular Endothelial Growth Factor in Patients with Renal Cell Carcinoma, Japanese Journal of Cancer Research, vol.88, issue.8, pp.874-883, 1999.
DOI : 10.1111/j.1349-7006.1999.tb00829.x

A. Schetter, S. Leung, J. Sohn, K. Zanetti, E. Bowman et al., MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma, JAMA, vol.299, issue.4, pp.425-461, 2008.
DOI : 10.1001/jama.299.4.425

S. Sengupta, J. Den-boon, I. Chen, M. Newton, S. Stanhope et al., MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins, Proceedings of the National Academy of Sciences, vol.105, issue.15, pp.5874-5882, 2008.
DOI : 10.1073/pnas.0801130105

R. Siegel, D. Naishadham, A. Jemal, and . Statistics, Cancer statistics, 2013, CA: A Cancer Journal for Clinicians, vol.287, issue.suppl 5, pp.11-30, 2013.
DOI : 10.3322/caac.21166

R. Siegel, D. Naishadham, and A. Jemal, Cancer statistics, 2013, CA: A Cancer Journal for Clinicians, vol.287, issue.suppl 5, pp.11-30, 2013.
DOI : 10.3322/caac.21166

K. Sisco, Is Rna in Serum Bound to Nucleoprotein Complexes?, Clin Chem, vol.47, issue.9, pp.1744-1749, 2001.

A. Skolarikos, G. Alivizatos, P. Laguna, and J. De-la-rosette, A Review on Follow-Up Strategies for Renal Cell Carcinoma after Nephrectomy, European Urology, vol.51, issue.6, pp.1490-500, 2007.
DOI : 10.1016/j.eururo.2006.12.031

O. Slaby, J. Jancovicova, R. Lakomy, M. Svoboda, A. Poprach et al., Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy, Journal of Experimental & Clinical Cancer Research, vol.29, issue.1, p.90
DOI : 10.1186/1756-9966-29-90

K. Smith, C. Jakubzick, T. Whittam, and J. Ferry, Carbonic anhydrase is an ancient enzyme widespread in prokaryotes, Proceedings of the National Academy of Sciences, vol.96, issue.26, pp.15184-15193, 1999.
DOI : 10.1073/pnas.96.26.15184

L. Sobin and C. Wittekind, Tnm Classification of Malignant Tumors, 0193.

M. Stroun, P. Anker, M. Beljanski, J. Henri, C. Lederrey et al., Presence of Rna in the Nucleoprotein Complex Spontaneously Released by Human Lymphocytes and Frog Auricles in Culture, Cancer Res, vol.38, issue.10, pp.3546-54, 1978.

M. Stroun, P. Anker, M. P. Gahan, and P. , Circulating Nucleic Acids in Higher Organisms, Int Rev Cytol, vol.51, pp.1-48, 1977.
DOI : 10.1016/S0074-7696(08)60225-9

M. Tamura, J. Gu, H. Tran, and K. Yamada, PTEN Gene and Integrin Signaling in Cancer, JNCI Journal of the National Cancer Institute, vol.91, issue.21, pp.1820-1828, 1999.
DOI : 10.1093/jnci/91.21.1820

G. Tang, X. Tang, V. Mendu, X. Jia, Q. Chen et al., The art of microRNA: Various strategies leading to gene silencing via an ancient pathway, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, vol.1779, issue.11, pp.1779-655, 2008.
DOI : 10.1016/j.bbagrm.2008.06.006

A. Tannapfel, H. Hahn, A. Katalinic, R. Fietkau, R. Kuhn et al., Prognostic value of ploidy and proliferation markers in renal cell carcinoma, Cancer, vol.12, issue.1, pp.164-71, 1996.
DOI : 10.1002/(SICI)1097-0142(19960101)77:1<164::AID-CNCR27>3.0.CO;2-2

C. Thery, L. Zitvogel, and S. Amigorena, Exosomes: Composition, Biogenesis and Function, Nat Rev Immunol, vol.2, issue.8, pp.569-79, 2002.

N. Tsui, E. Ng, and Y. Lo, Stability of Endogenous and Added Rna in Blood Specimens, Serum, and Plasma, Clin Chem, vol.48, issue.10, pp.1647-53, 2002.

M. Tsujiura, D. Ichikawa, S. Komatsu, A. Shiozaki, H. Takeshita et al., Circulating microRNAs in plasma of patients with gastric cancers, British Journal of Cancer, vol.6, issue.7, pp.1174-1183, 2010.
DOI : 10.1038/labinvest.2008.94

A. Turchinovich, L. Weiz, A. Langheinz, and B. Burwinkel, Characterization of extracellular circulating microRNA, Nucleic Acids Research, vol.39, issue.16, pp.7223-7256, 2011.
DOI : 10.1093/nar/gkr254

T. Uchida, C. Wada, C. Wang, S. Egawa, H. Ohtani et al., Genomic Instability of Microsatellite Repeats and Mutations of H-, K-, and N-Ras, and P53 Genes in Renal Cell Carcinoma, Cancer Res, vol.54, issue.14, pp.3682-3687, 1994.

V. Urquidi, C. Rosser, and S. Goodison, Molecular Diagnostic Trends in Urological Cancer: Biomarkers for Non-Invasive Diagnosis, Current Medicinal Chemistry, vol.19, issue.22, pp.3653-63, 2012.
DOI : 10.2174/092986712801661103

H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J. Lee et al., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nature Cell Biology, vol.175, issue.6, pp.654-663, 2007.
DOI : 10.1002/pmic.200400876

G. Van-niel, I. Porto-carreiro, S. Simoes, and G. Raposo, Exosomes: A Common Pathway for a Specialized Function, Journal of Biochemistry, vol.140, issue.1, pp.13-21, 2006.
DOI : 10.1093/jb/mvj128

K. Vickers, B. Palmisano, B. Shoucri, R. Shamburek, and A. Remaley, MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, Nature Cell Biology, vol.257, issue.4, pp.423-456, 2011.
DOI : 10.1073/pnas.011404098

G. Wang, E. Chan, B. Kwan, P. Li, S. Yip et al., Expression of microRNAs in the Urine of Patients With Bladder Cancer, Clinical Genitourinary Cancer, vol.10, issue.2, pp.106-119, 2012.
DOI : 10.1016/j.clgc.2012.01.001

K. Wang, S. Zhang, B. Marzolf, P. Troisch, A. Brightman et al., Circulating microRNAs, potential biomarkers for drug-induced liver injury, Proceedings of the National Academy of Sciences, vol.106, issue.11, pp.4402-4409, 2009.
DOI : 10.1073/pnas.0813371106

K. Wang, S. Zhang, J. Weber, D. Baxter, and D. Galas, Export of microRNAs and microRNA-protective protein by mammalian cells, Nucleic Acids Research, vol.38, issue.20, pp.7248-59, 2010.
DOI : 10.1093/nar/gkq601

L. Wang, Y. B. Yang, Q. Qiao, S. Wang, Y. Sun et al., Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis, Clinical & Experimental Metastasis, vol.86, issue.6, pp.1049-54, 2009.
DOI : 10.1007/s10585-009-9294-3

S. Wang, A. Aurora, B. Johnson, X. Qi, J. Mcanally et al., The Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis, Developmental Cell, vol.15, issue.2, pp.261-71, 2008.
DOI : 10.1016/j.devcel.2008.07.002

J. Weber, D. Baxter, S. Zhang, D. Huang, K. Huang et al., The MicroRNA Spectrum in 12 Body Fluids, Clinical Chemistry, vol.56, issue.11, pp.1733-1774, 2010.
DOI : 10.1373/clinchem.2010.147405

J. Weiler, J. Hunziker, and J. Hall, Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?, Gene Therapy, vol.392, issue.6, pp.496-502, 2006.
DOI : 10.1038/sj.gt.3302654

G. Weiss, L. Bemis, E. Nakajima, M. Sugita, D. Birks et al., EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines, Annals of Oncology, vol.19, issue.6, pp.1053-1062, 2008.
DOI : 10.1093/annonc/mdn006

N. White and G. Yousef, MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer, BMC Medicine, vol.389, issue.1, p.65, 2010.
DOI : 10.1515/BC.2008.068

A. Wieczorek, C. Rhyner, and L. Block, Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans., Proceedings of the National Academy of Sciences, vol.82, issue.10, pp.3455-3464, 1985.
DOI : 10.1073/pnas.82.10.3455

L. Wulfken, R. Moritz, C. Ohlmann, S. Holdenrieder, V. Jung et al., MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels, PLoS ONE, vol.50, issue.9, p.25787, 2011.
DOI : 10.1371/journal.pone.0025787.s002

Y. Youssef, N. White, J. Grigull, A. Krizova, C. Samy et al., Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature, European Urology, vol.59, issue.5, pp.721-751, 2011.
DOI : 10.1016/j.eururo.2011.01.004

Y. Zhang, D. Liu, X. Chen, J. Li, L. Li et al., Secreted Monocytic miR-150 Enhances Targeted Endothelial Cell Migration, Molecular Cell, vol.39, issue.1, pp.133-177, 2010.
DOI : 10.1016/j.molcel.2010.06.010

URL : http://doi.org/10.1016/j.molcel.2010.06.010

A. Zhao, G. Li, M. Peoc-'h, C. Genin, and M. Gigante, Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma, Experimental and Molecular Pathology, vol.94, issue.1, pp.115-135, 2012.
DOI : 10.1016/j.yexmp.2012.10.005

H. Zhou, J. Guo, Y. Lou, X. Zhang, F. Zhong et al., Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker, Journal of Molecular Medicine, vol.7, issue.7, pp.709-726, 2010.
DOI : 10.1007/s00109-010-0617-2

S. Zhu, H. Wu, F. Wu, D. Nie, S. Sheng et al., MicroRNA-21 targets tumor suppressor genes in invasion and metastasis, Cell Research, vol.60, issue.3, pp.350-359, 2008.
DOI : 10.1016/j.bbrc.2006.02.106

W. Zundel, C. Schindler, D. Haas-kogan, A. Koong, F. Kaper et al., Loss of Pten Facilitates Hif-1-Mediated Gene Expression, Genes Dev, vol.14, issue.4, pp.391-397, 2000.

A. Zhao, G. Li, M. Péoc-'h, C. Genin, and M. Gigante, Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma, Experimental and Molecular Pathology, vol.94, issue.1, 2009.
DOI : 10.1016/j.yexmp.2012.10.005

A. Zhao, M. Péoc-'h, C. Genin, N. Mottet, and G. Li, Cell-free RNA content in urine as a possible molecular diagnostic tool for clear cell renal cell carcinoma, International Journal of Cancer, vol.31, issue.11
DOI : 10.1002/ijc.29313

A. Zhao, M. Péoc-'h, C. Genin, N. Mottet, and G. Li, Detection of urinary cell-free microRNAs in clear cell renal cell carcinoma

G. Li, G. Badin, A. Zhao, A. Gentil-perret, J. Tostain et al., Prognostic value of CXCR4 expression in patients with clear cell renal cell carcinoma, 2013.

G. Li, M. Cuilleron, A. Zhao, F. Obadia, P. Mouracade et al., Combination of core biopsy and fine-needle aspiration increases diagnostic rate for small solid renal tumors, Anticancer Res, vol.32, issue.8, pp.3463-3469, 2012.

M. Gigante, G. Li, C. Ferlay, D. Perol, E. Blanc et al., Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapy, Anticancer Res, vol.32, issue.12, pp.5447-51, 2012.

G. Li, I. Bilal, A. Gentil-perret, G. Feng, A. Zhao et al., CA9 as a molecular marker for differential diagnosis of cystic renal tumors, Urologic Oncology: Seminars and Original Investigations, vol.30, issue.4, 2010.
DOI : 10.1016/j.urolonc.2010.04.014

F. Gang, L. Guorong, Z. An, G. Anne, G. Christian et al., Prediction of Clear Cell Renal Cell Carcinoma by Integrity of Cell-free DNA in Serum, Urology, vol.75, issue.2, 2009.
DOI : 10.1016/j.urology.2009.06.048

G. Li, G. Feng, M. Cuilleron, A. Zhao, A. Gentil-perret et al., CA9 level in renal cyst fluid: a possible molecular diagnosis of malignant tumours, Histopathology, vol.12, issue.7, 2009.
DOI : 10.1111/j.1365-2559.2009.03302.x